NVP-BGT226 - BGT 226

Based on 8 reference(s) in Google Scholar 9 10 8

Axon 2029

CAS [1245537-68-1]

MF C28H25F3N6O2.C4H4O4
MW 650.60

  • Purity: 99%
  • Soluble in DMSO

NVP-BGT226

Description

Orally active dual PI3K/mTOR inhibitor; induces cell cycle arrest and regulates survivin gene expression in human pancreatic cancer cell lines; inhibits growth in common myeloma cell lines and primary myeloma cells at nanomolar concentrations in a time-dependent and dose-dependent manner
Order
Size Unit Price Stock
5 mg €120.00 In Stock
25 mg €420.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €180.00 In Stock
2 x 25 mg €620.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...